GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 743 filers reported holding GLAXOSMITHKLINE PLC in Q1 2015. The put-call ratio across all filers is 1.95 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $1,661,000 | +86.0% | 38,155 | +86.2% | 0.32% | +109.8% |
Q1 2022 | $893,000 | +50.8% | 20,490 | +52.6% | 0.15% | +36.6% |
Q4 2021 | $592,000 | +187.4% | 13,425 | +162.0% | 0.11% | +154.5% |
Q3 2018 | $206,000 | -74.1% | 5,125 | -74.1% | 0.04% | -74.4% |
Q2 2018 | $796,000 | -31.7% | 19,755 | -33.8% | 0.17% | -32.0% |
Q1 2018 | $1,165,000 | -51.7% | 29,830 | -56.1% | 0.25% | -51.5% |
Q4 2017 | $2,413,000 | -46.7% | 68,025 | -38.9% | 0.52% | -49.6% |
Q3 2017 | $4,523,000 | -7.6% | 111,410 | -1.9% | 1.04% | -8.2% |
Q2 2017 | $4,897,000 | +1.3% | 113,565 | -1.0% | 1.13% | +0.7% |
Q1 2017 | $4,836,000 | +20.3% | 114,695 | +9.9% | 1.12% | +16.2% |
Q4 2016 | $4,020,000 | +68.3% | 104,390 | +88.6% | 0.96% | +61.9% |
Q3 2016 | $2,388,000 | +0.5% | 55,360 | +1.0% | 0.60% | +1.0% |
Q2 2016 | $2,375,000 | +10.2% | 54,810 | +3.2% | 0.59% | +5.0% |
Q1 2016 | $2,155,000 | +2.4% | 53,135 | +1.9% | 0.56% | -0.5% |
Q4 2015 | $2,104,000 | +121.7% | 52,145 | +134.8% | 0.56% | +150.0% |
Q1 2015 | $949,000 | – | 22,205 | – | 0.23% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |